Wednesday, September 23, 2020

Inside Perspectives on Cancer Immunotherapy: An Interview with MPM’s Christiana Bardon

Boston-based MPM Capital’s Christiana Bardon, M.D., describes immunotherapy as an exciting, transformative field in cancer treatment. She foresees dramatic improvements for patients over the next 10 years. “We’ve just turned the corner...

China Turns to Precision Medicine in Fight Against Cancer

The gulf between how many Americans say, in a survey, that they would like to use digital health services and how many actually have is still quite large, according to a...

Finding Solutions to Rare Diseases through Genomics: An Interview with Hannes Smárason, WuXi NextCODE

Hannes Thor Smárason co-founded NextCODE Health in 2013 along with Dr. Jeff Gulcher and currently serves at COO of WuXi NextCODE. Previously, Mr. Smárason served as Chief Financial Officer and Executive...

Combining Service and Investment: An Interview with Wei Li, Co-Founder of WuXi Healthcare Ventures

Dr. Wei Li joined us early this year to co-found WuXi Healthcare Ventures (“WXHV”) with WuXi AppTec (“WX”) CFO, Ed Hu and CEO, Dr. Ge Li. WXHV identifies and partners with...

Developing a Novel ADC for Global Market via Innovative Three-party Collaboration – An Interview...

Recently, Dr. Jiawen Han, Vice President of ADC Technology at WuXi Biologics (a wholly owned subsidiary of WuXi AppTec), presented at the 1St DIA China Drug Discovery and Innovation Conference.  His...

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WuXi NEWS